(By Martha Bebinger, WBUR for Kaiser Health News)
Prescriptions for two drugs used to treat opioid addiction increased significantly from 2016 to 2018 for people on Medicare, according to a federal report out Wednesday.
About 174,000 Medicare beneficiaries received such a medication — either buprenorphine or naltrexone — to help them with recovery in 2018, according to the Office of Inspector General in the Department of Health and Human Services.
In addition, prescriptions for naloxone, the drug that can reverse an opioid overdose, spiked since 2016, rising 501% ― and that is likely an underestimate because it doesn’t include doses of the nasal spray Medicare members might have received through local programs, the OIG said. Continue reading article here…
Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.